Abbott Laboratories (ABT) Earnings Date, Estimates & Call Transcripts

$117.82

+1.77 (+1.53%)

(As of 10/16/2024 ET)

Latest Earnings Date: Jul. 18Confirmed
Actual EPS (Jul. 18): $1.14 Beat By $0.04
Consensus EPS (Jul. 18): $1.10

ABT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad DTI

Here’s how to start a “Weekend Side Hustle” from your sofa

Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand. And that’s how you can kickstart your very own “Weekend Side Hustle!” Now that you know that…

Let me show you how I target extra income as early as THIS weekend!

Abbott Laboratories Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	2	$0.96	$1.03	$1.00
Q2 2024	2	$1.10	$1.13	$1.12	1.080 - 1.120
Q3 2024	2	$1.18	$1.19	$1.19	1.180 - 1.220
Q4 2024	2	$1.23	$1.34	$1.29	1.310 - 1.370
FY 2024	8	$4.47	$4.69	$4.58
Q1 2025	2	$1.13	$1.26	$1.20
Q2 2025	2	$1.26	$1.28	$1.27
Q3 2025	2	$1.24	$1.31	$1.28
Q4 2025	1	$1.42	$1.42	$1.42
FY 2025	7	$5.05	$5.27		$5.16

ABT Earnings Date and Information

Abbott Laboratories last announced its quarterly earnings data on October 16th, 2024. The healthcare product maker reported $1.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.01. The business had revenue of $10.64 billion for the quarter, compared to analysts' expectations of $10.55 billion. Its revenue was up 4.9% on a year-over-year basis. Abbott Laboratories has generated $3.21 earnings per share over the last year ($3.21 diluted earnings per share) and currently has a price-to-earnings ratio of 37.2. Earnings for Abbott Laboratories are expected to grow by 10.09% in the coming year, from $4.66 to $5.13 per share. Abbott Laboratories has confirmed that its next quarterly earnings report will be published on Wednesday, October 16th, 2024.

Abbott Laboratories Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
7/18/2024	Q2 2024	$1.10	$1.14	+$0.04	$1.54	$10.37 billion	$10.38 billion
4/17/2024	Q1 2024	$0.96	$0.98	+$0.02	$1.26	$9.88 billion	$9.96 billion
1/24/2024	Q4 2023	$1.19	$1.19	-	$1.47	$10.19 billion	$10.24 billion
10/18/2023	Q3 2023	$1.10	$1.14	+$0.04	$1.46	$9.82 billion	$10.14 billion
7/20/2023	Q2 2023	$1.05	$1.08	+$0.03	$1.38	$9.71 billion	$9.98 billion
4/19/2023	Q1 2023	$0.98	$1.03	+$0.05	$1.31	$9.64 billion	$9.75 billion
A Totally New ‘Income Coin’ (Ad) Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, it's such a radical departure from what most people think of when it comes to typical income strategies, I'm calling it: The Perfect Income Altcoin Click here to get access to my 'Perfect Income Altcoin' for just $3 today.
1/25/2023	Q4 2022	$0.90	$1.03	+$0.13	$1.47	$9.69 billion	$10.09 billion
10/19/2022	Q3 2022	$0.90	$1.15	+$0.25	$1.49	$9.65 billion	$10.41 billion
7/20/2022	Q2 2022	$1.09	$1.43	+$0.34	$1.72	$10.37 billion	$11.26 billion
4/20/2022	Q1 2022	$1.47	$1.73	+$0.26	$2.09	$11.00 billion	$11.90 billion
1/26/2022	Q4 2021	$1.18	$1.32	+$0.14	$1.53	$10.71 billion	$11.47 billion
10/19/2021	Q3 2021	$0.94	$1.40	+$0.46	$1.63	$9.56 billion	$10.93 billion
7/21/2021	Q2 2021	$1.02	$1.17	+$0.15	$1.68	$9.67 billion	$10.22 billion
4/19/2021	Q1 2021	$1.27	$1.32	+$0.05	$1.64	$10.72 billion	$10.45 billion
1/26/2021	Q4 2020	$1.35	$1.45	+$0.10	$1.70	$9.94 billion	$10.70 billion
10/21/2020	Q3 2020	$0.90	$0.98	+$0.08	$1.27	$8.53 billion	$8.85 billion
7/16/2020	Q2 2020	$0.42	$0.57	+$0.15	$0.84	$6.85 billion	$7.33 billion
4/16/2020	Q1 2020	$0.58	$0.65	+$0.07	$0.99	$7.47 billion	$7.73 billion
1/22/2020	Q4 2019	$0.95	$0.95	-	$1.31	$8.26 billion	$8.31 billion

Abbott Laboratories Earnings - Frequently Asked Questions

When is Abbott Laboratories's earnings date?: Abbott Laboratories has confirmed that its next quarterly earnings data will be published on Wednesday, October 16th, 2024. Learn more on ABT's earnings history.
What guidance has Abbott Laboratories issued on next quarter's earnings?: Abbott Laboratories updated its FY 2024 earnings guidance on Wednesday, October, 16th. The company provided earnings per share (EPS) guidance of 4.640-4.700 for the period, compared to the consensus estimate of 4.660. The company issued revenue guidance of -.
Did Abbott Laboratories beat their earnings estimates last quarter?: In the previous quarter, Abbott Laboratories (NYSE:ABT) reported $1.21 earnings per share (EPS) to beat the analysts' consensus estimate of $1.20 by $0.01. Learn more on analysts' earnings estimate vs. ABT's actual earnings.
How can I listen to Abbott Laboratories's earnings conference call?: The conference call for Abbott Laboratories's latest earnings report can be listened to online. Listen to Conference Call
How can I read Abbott Laboratories's conference call transcript?: The conference call transcript for Abbott Laboratories's latest earnings report can be read online. Read Transcript
How much revenue does Abbott Laboratories generate each year?: Abbott Laboratories (NYSE:ABT) has a recorded annual revenue of $40.73 billion.
How much profit does Abbott Laboratories generate each year?: Abbott Laboratories (NYSE:ABT) has a recorded net income of $5.72 billion. ABT has generated $3.21 earnings per share over the last four quarters.
What is Abbott Laboratories's price-to-earnings ratio?: Abbott Laboratories (NYSE:ABT) has a trailing price-to-earnings ratio of 37.17 and a forward price-to-earnings ratio of 25.28. The price/earnings-to-growth ratio is 2.74.
What is Abbott Laboratories's EPS forecast for next year?: Abbott Laboratories's earnings are expected to grow from $4.66 per share to $5.13 per share in the next year, which is a 10.09% increase.